SM: Take me back to where your story begins. What is your background? PF: I was born just outside of London. My father is a professor of chemistry and my mother is an ancient history high school teacher.
SM: How did you finance this company? Is it also a venture-funded company? SS: It was funded by a select few angel investors and a private equity firm.
SM: Your background is not in technology. Where does your company’s technology come from? What you are suggesting is not an easy problem to solve. SS: It is definitely not an easy problem to solve. Form follows function. The most important thing is to lay out and articulate our approach to the marketplace and show
SM: It sounds as though physicians need to be on some form of EMR system to use Phytel. Is that correct? SS: No. If we had architected our solution to be dependent on EMR, then we would only have access to 5%-10% of the marketplace. We can access EMR data, and we will do more
SM: What happened after you sold Accordant? Did you have to stay as part of the deal? SS: It was a very friendly, good arrangement when we were purchased. I was enthusiastic about sticking around. They wanted me to stay and I was excited to do so. My right-hand person continues to lead Accordant today.
SM: What was your value proposition? SS: Our value proposition was straightforward. Those diseases cost an enormous amount of money and they were out on the fringe, so nobody was really paying attention to them.
SM: Was Home Healthcare of America, your first exposure to a venture business, successful? SS: It was hugely successful. It has become Caremark, which is one of the biggest in the world. I stayed there for just under three years and then they were bought by Baxter. That was the second time I worked for a
SM: What is your background? Where did you grow up and where do you come from? SS: I grew up all over because my father was in the US military. I lived in a half dozen different states in the US as well as in Europe before I even got out of high school, and